SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Adherence to CONSORT harms-reporting recommendations in publications of recent analgesic clinical trials: An ACTTION systematic review
16 references·16 citing·38 second hopsampled
Adherence to CONSORT harms-reporting recommendations in publications of recent analgesic clinical trials: An ACTTION systematic review (2012)Adherence to CONSORT harms-reporting reco…The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed (2010)The quality of reports of ran…CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomized Trials (2010)CONSORT 2010 Statement: Updat…CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials (2010)CONSORT 2010 Statement: updat…Reporting of Safety Results in Published Reports of Randomized Controlled Trials (2009)Reporting of Safety Results i…Differences in Adverse Effect Reporting in Placebo Groups in SSRI and Tricyclic Antidepressant Trials (2009)Differences in Adverse Effect…Reporting in randomized clinical trials improved after adoption of the CONSORT statement (2006)Reporting in randomized clini…Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review (2006)Does the CONSORT checklist im…The quality of randomized trial reporting in leading medical journals since the revised CONSORT statement (2005)The quality of randomized tri…Empirical Evidence for Selective Reporting of Outcomes in Randomized Trials (2004)Empirical Evidence for Select…Better Reporting of Harms in Randomized Trials: An Extension of the CONSORT Statement (2004)Better Reporting of Harms in …Core outcome domains for chronic pain clinical trials: IMMPACT recommendations (2003)Core outcome domains for chro…Use of the CONSORT Statement and Quality of Reports of Randomized Trials (2001)Use of the CONSORT Statement …The CONSORT Statement: Revised Recommendations for Improving the Quality of Reports of Parallel-Group Randomized Trials (2001)The CONSORT Statement: Revise…The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials (2001)The CONSORT statement: revise…Improving the quality of reporting of randomized controlled trials. The CONSORT statement (1996)Improving the quality of repo…Improving the Quality of Reporting of Randomized Controlled Trials (1996)Improving the Quality of Repo…Quality of reporting and concordance between sources of adverse events in the treatment of moderate-to-severe psoriasis: a cross-sectional study of RCTs from a Cochrane systematic review (2024)Quality of reporting and conc…Harms-related data are poorly reported among randomized controlled trials underpinning the American Academy of Orthopaedic Surgeons clinical practice guideline recommendations for rotator cuff injuries (2022)Harms-related data are poorly…Identification, collection, and reporting of harms among non-industry-sponsored randomized clinical trials of pharmacologic interventions in the critically ill population: a systematic review (2020)Identification, collection, a…Adherence to Consolidated Standards of Reporting Trials (CONSORT) Guidelines for Reporting Safety Outcomes in Trials of Medical Cannabis and Cannabis-based Medicines for Chronic Noncancer Pain (2020)Adherence to Consolidated Sta…Spin in the reporting, interpretation, and extrapolation of adverse effects of orthodontic interventions: protocol for a cross-sectional study of systematic reviews (2019)Spin in the reporting, interp…Recommendations for the Reporting of Harms in Manuscripts on Clinical Trials Assessing Osteoarthritis Drugs: A Consensus Statement from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) (2019)Recommendations for the Repor…The reporting of harms in publications on randomized controlled trials funded by the “Programme Hospitalier de Recherche Clinique,” a French academic funding scheme (2018)The reporting of harms in pub…Inadequate harms reporting in randomized control trials of antibiotics for pediatric acute otitis media: a systematic review (2018)Inadequate harms reporting in…Quality of reporting of harms in randomised controlled trials of pharmacological interventions for rheumatoid arthritis: a systematic review (2017)Quality of reporting of harms…Checklist for the preparation and review of pain clinical trial publications: a pain-specific supplement to CONSORT (2017)Checklist for the preparation…Adverse Event Reporting in Clinical Trials of Intravenous and Invasive Pain Treatments: An ACTTION Systematic Review (2016)Adverse Event Reporting in Cl…Mythbusting Medical Writing: Goodbye, Ghosts! Hello, Help! (2015)Mythbusting Medical Writing: …Deficiencies in reporting of statistical methodology in recent randomized trials of nonpharmacologic pain treatments: ACTTION systematic review (2015)Deficiencies in reporting of …Adverse event methods were heterogeneous and insufficiently reported in randomized trials on persistent depressive disorder (2015)Adverse event methods were he…Adverse event reporting in nonpharmacologic, noninterventional pain clinical trials: ACTTION systematic review (2014)Adverse event reporting in no…Adverse event assessment, analysis, and reporting in recent published analgesic clinical trials: ACTTION systematic review and recommendations (2013)Adverse event assessment, ana…Reporting results of cancer treatment (1981)The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials (2001)The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration (2001)The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement (2007)CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials (2010)CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials (2010)An Inventory for Measuring Depression (1961)The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. (1992)Acceptance-based interventions for the treatment of chronic pain: A systematic review and meta-analysis (2011)Developing core outcome sets for clinical trials: issues to consider (2012)The COMET Handbook: version 1.0 (2017)Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement (2009)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (2009)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. (2009)SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials (2013)CONSORT 2010 statement: extension to randomised pilot and feasibility trials (2016)CONSORT 2010 statement: extension to randomised pilot and feasibility trials (2016)Experimental and Quasi-Experimental Designs for Research (1963)Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials (1995)Assessing the quality of reports of randomized clinical trials: Is blinding necessary? (1996)Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy. (2003)Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups (2007)The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies (2007)Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide (2014)Standards for Reporting Qualitative Research (2014)Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation (2015)Empirical Evidence of Bias (1995)Meta-analysis of Observational Studies in Epidemiology A Proposal for Reporting (2000)The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies (2007)Cochrane Handbook for Systematic Reviews of Interventions (2008)Systematic Reviews: Identifying relevant studies for systematic reviews (1994)Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses? (1998)Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration (2007)Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement (1999)Assessing the quality of controlled clinical trials (2001)Towards Complete and Accurate Reporting of Studies of Diagnostic Accuracy: The STARD Initiative (2003)Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis (2007)Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry (2008)
this work references cited by second hop· second hop is a sample of the most-cited connections

References

  • 2010CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials13,365 cited
  • 2001The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials5,372 cited
  • 2010CONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomized Trials3,824 cited
  • 2003Core outcome domains for chronic pain clinical trials: IMMPACT recommendations3,496 cited
  • 1996Improving the quality of reporting of randomized controlled trials. The CONSORT statement3,337 cited
  • 1996Improving the Quality of Reporting of Randomized Controlled Trials3,126 cited
  • 2001The CONSORT Statement: Revised Recommendations for Improving the Quality of Reports of Parallel-Group Randomized Trials2,545 cited
  • 2004Empirical Evidence for Selective Reporting of Outcomes in Randomized Trials1,845 cited
  • 2004Better Reporting of Harms in Randomized Trials: An Extension of the CONSORT Statement1,588 cited
  • 2001Use of the CONSORT Statement and Quality of Reports of Randomized Trials1,026 cited
  • 2006Does the CONSORT checklist improve the quality of reports of randomised controlled trials? A systematic review873 cited
  • 2010The quality of reports of randomised trials in 2000 and 2006: comparative study of articles indexed in PubMed503 cited
  • 2009Reporting of Safety Results in Published Reports of Randomized Controlled Trials285 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

  • 2006Reporting in randomized clinical trials improved after adoption of the CONSORT statement227 cited
  • 2005The quality of randomized trial reporting in leading medical journals since the revised CONSORT statement216 cited
  • 2009Differences in Adverse Effect Reporting in Placebo Groups in SSRI and Tricyclic Antidepressant Trials202 cited
  • Cited by

    • 2013Adverse event assessment, analysis, and reporting in recent published analgesic clinical trials: ACTTION systematic review and recommendations58 cited
    • 2015Adverse event methods were heterogeneous and insufficiently reported in randomized trials on persistent depressive disorder45 cited
    • 2017Checklist for the preparation and review of pain clinical trial publications: a pain-specific supplement to CONSORT45 cited
    • 2014Adverse event reporting in nonpharmacologic, noninterventional pain clinical trials: ACTTION systematic review27 cited
    • 2017Quality of reporting of harms in randomised controlled trials of pharmacological interventions for rheumatoid arthritis: a systematic review27 cited
    • 2018Inadequate harms reporting in randomized control trials of antibiotics for pediatric acute otitis media: a systematic review26 cited
    • 2019Recommendations for the Reporting of Harms in Manuscripts on Clinical Trials Assessing Osteoarthritis Drugs: A Consensus Statement from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO)20 cited
    • 2016Adverse Event Reporting in Clinical Trials of Intravenous and Invasive Pain Treatments: An ACTTION Systematic Review19 cited
    • 2020Identification, collection, and reporting of harms among non-industry-sponsored randomized clinical trials of pharmacologic interventions in the critically ill population: a systematic review19 cited
    • 2018The reporting of harms in publications on randomized controlled trials funded by the “Programme Hospitalier de Recherche Clinique,” a French academic funding scheme19 cited
    • 2015Mythbusting Medical Writing: Goodbye, Ghosts! Hello, Help!18 cited
    • 2019Spin in the reporting, interpretation, and extrapolation of adverse effects of orthodontic interventions: protocol for a cross-sectional study of systematic reviews18 cited
    • 2015Deficiencies in reporting of statistical methodology in recent randomized trials of nonpharmacologic pain treatments: ACTTION systematic review17 cited
    • 2020Adherence to Consolidated Standards of Reporting Trials (CONSORT) Guidelines for Reporting Safety Outcomes in Trials of Medical Cannabis and Cannabis-based Medicines for Chronic Noncancer Pain14 cited
    • 2024Quality of reporting and concordance between sources of adverse events in the treatment of moderate-to-severe psoriasis: a cross-sectional study of RCTs from a Cochrane systematic review13 cited
    • 2022Harms-related data are poorly reported among randomized controlled trials underpinning the American Academy of Orthopaedic Surgeons clinical practice guideline recommendations for rotator cuff injuries12 cited